Meta-Analysis on Long-Term Outcomes of Pediatric Renal Cancer Survivors Following COG and SIOP Protocols

Abstract

Background Pediatric renal cancer survivors have higher rate of chronic renal disease and hypertension. These patients have similar survival rates when treated according to either Children's Oncology Group (COG) or International Society of Pediatric Oncology (SIOP) protocols. We aimed to compare the late outcome of these two approaches.

Methods We performed a meta-analysis of all studies from 2000 to 2021; database search using keywords: long-term outcomes OR late effects, nephrectomy, pediatric renal cancer. For each protocol, data were collected, and the “pooled” outcomes were compared. Continuous and dichotomous variables were obtained with a 95% odds ratio.

Results Sixteen studies with a total of 715 pediatric renal cancer survivors were analyzed. The mean follow-up time was 17.4 (standard deviation 5.6) years. Reduced renal function and hypertension were the most encountered long-term complications. The mean estimated glomerular filtration rate was similar in both protocols (101.62 vs. 101.70 mL/min/1.73 m²), while the prevalence of hypertension was 23% in COG and 10% in SIOP. The prevalence of secondary malignancy was 1.1% in COG and 6.7% in SIOP (1.1% vs. 6.7%, p ≤ 0.001). Chronic kidney disease was similar in both groups.

Conclusion A high prevalence of hypertension was observed among pediatric renal cancer survivors, as well as an increased risk of a secondary tumor. These results emphasize the importance of long-term follow-up into adulthood, to promptly diagnose any long-term side effects of the treatment. Thanks to the increased overall survival, future protocols will pay attention to the reduction of long-term sequelae.

Keywords

pediatric renal cancer - long-term follow-up - side effect of cancer surgery

^* These authors contributed equally to the research and retain the first authorship.

Publikationsverlauf

Eingereicht: 03. Juni 2022

Angenommen: 22. August 2022

Artikel online veröffentlicht:
26. Dezember 2022

• References

• 1 Ooms AHAG, Vujanić GM, D'Hooghe E. et al. Renal tumors of childhood-a histopathologic pattern-based diagnostic approach. Cancers (Basel) 2020; 12 (03) 729
• 2 Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®)–Health Professional Version - NCI. Accessed May 30, 2022, at: https://www.cancer.gov/types/kidney/hp/wilms-treatment-pdq#cit/section_2.144
• 3 Vujanić GM, Gessler M, Ooms AHAG. et al; International Society of Paediatric Oncology–Renal Tumour Study Group (SIOP–RTSG). The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol. Nat Rev Urol 2018; 15 (11) 693-701
• 4 Wang J, Li M, Tang D, Gu W, Mao J, Shu Q. Current treatment for Wilms tumor: COG and SIOP standards. World Jnl Ped Surgery 2019; 2: 38
• 5 Vujanić GM, Parsons LN, D'Hooghe E, Treece AL, Collini P, Perlman EJ. Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's Oncology Group (COG) renal tumour studies: similarities and differences. Histopathology 2022; 80 (07) 1026-1037
• 6 Cooke-Barber J, Scorletti F, Rymeski B. et al. Long-term follow-up of surgical outcomes for patients with Wilms tumor and neuroblastoma. Cancer 2021; 127 (17) 3232-3238
• 7 Neu MA, Russo A, Wingerter A. et al. Prospective analysis of long-term renal function in survivors of childhood Wilms tumor. Pediatr Nephrol 2017; 32 (10) 1915-1925
• 8 Schiavetti A, Altavista P, De Luca L, Andreoli G, Megaro G, Versacci P. Long-term renal function in unilateral non-syndromic renal tumor survivors treated according to International Society of Pediatric Oncology protocols. Pediatr Blood Cancer 2015; 62 (09) 1637-1644
• 9 Interiano RB, Delos Santos N, Huang S. et al. Renal function in survivors of nonsyndromic Wilms tumor treated with unilateral radical nephrectomy. Cancer 2015; 121 (14) 2449-2456
• 10 Kern AJM, Inouye B, Ko JS. et al. Impact of nephrectomy on long-term renal function in non-syndromic children treated for unifocal Wilms tumor. J Pediatr Urol 2014; 10 (04) 662-666
• 11 Interiano RB, McCarville MB, Santos ND. et al. Comprehensive renal function evaluation in patients treated for synchronous bilateral Wilms tumor. J Pediatr Surg 2017; 52 (01) 98-103
• 12 Chu DI, Ehlayel AM, Ginsberg JP. et al. Kidney outcomes and hypertension in survivors of Wilms tumor: a prospective cohort study. J Pediatr 2021; 230: 215-220 .e1
• 13 Indolfi P, Di Tullio MT, Casale F, De Rosa E, Polito C, Cioce F. Kidney size and function after unilateral nephrectomy for Wilms tumor: a longitudinal study. Med Pediatr Oncol 2001; 37 (05) 485-486
• 14 Friesenbichler W, Lüftinger R, Kropshofer G. et al. Clear cell sarcoma of the kidney in Austrian children: long-term survival after relapse. Pediatr Blood Cancer 2021; 68 (05) e28860
• 15 Mavinkurve-Groothuis AMC, van de Kracht F, Westland R, van Wijk JAE, Loonen JJ, Schreuder MF. Long-term follow-up of blood pressure and glomerular filtration rate in patients with a solitary functioning kidney: a comparison between Wilms tumor survivors and nephrectomy for other reasons. Pediatr Nephrol 2016; 31 (03) 435-441
• 16 Giel DW, Williams MA, Jones DP, Davidoff AM, Dome JS. Renal function outcomes in patients treated with nephron sparing surgery for bilateral Wilms tumor. J Urol 2007;178(4 Pt 2):1786–1789, discussion 1789–1790
• 17 Aronson DC, Slaar A, Heinen RC, de Kraker J, Heij HA. Long-term outcome of bilateral Wilms tumors (BWT). Pediatr Blood Cancer 2011; 56 (07) 1110-1113
• 18 Spreafico F, Terenziani M, Testa S. et al. Long-term renal outcome in adolescent and young adult patients nephrectomized for unilateral Wilms tumor. Pediatr Blood Cancer 2014; 61 (06) 1136-1137
• 19 Elli M, Sungur M, Genç G. et al. The late effects of anticancer therapy after childhood Wilms tumor: the role of diastolic function and ambulatory blood pressure monitoring. Jpn J Clin Oncol 2013; 43 (10) 1004-1011
• 20 van Dijk IWEM, Oldenburger F, Cardous-Ubbink MC. et al. Evaluation of late adverse events in long-term Wilms' tumor survivors. Int J Radiat Oncol Biol Phys 2010; 78 (02) 370-378
• 21 Green DM, Wang M, Krasin MJ. et al. Long-term renal function after treatment for unilateral, nonsyndromic Wilms tumor. A report from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 2020; 67 (10) e28271
• 22 Green DM, Breslow NE, D'Angio GJ. et al. Outcome of patients with Stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 2014; 61 (01) 134-139
• 23 Kist-van Holthe JE, Ho PL, Stablein D, Harmon WE, Baum MA. Outcome of renal transplantation for Wilms' tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2005; 9 (03) 305-310
• 24 Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol 2005; 174 (05) 1972-1975
• 25 Cozzi F, Schiavetti A, Morini F. et al. Renal function adaptation in children with unilateral renal tumors treated with nephron sparing surgery or nephrectomy. J Urol 2005; 174 (4 Pt 1): 1404-1408
• 26 Selistre L, Rabilloud M, Cochat P. et al. Comparison of the Schwartz and CKD-EPI equations for estimating glomerular filtration rate in children, adolescents, and adults: a retrospective cross-sectional study. PLoS Med 2016; 13 (03) e1001979